Characterizing treatment resistance in muscle invasive bladder cancer using the chicken egg chorioallantoic membrane patient-derived xenograft model

BACKGROUND: Non-metastatic muscle invasive urothelial bladder cancer (MIBC) has a poor prognosis and standard of care (SOC) includes neoadjuvant cisplatin-based chemotherapy (NAC) combined with cystectomy. Patients receiving NAC have at best <10% improvement in five-year overall survival compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Villanueva, Hugo, Wells, Gabrielle A., Miller, Malachi T., Villanueva, Mariana, Pathak, Ravi, Castro, Patricia, Ittmann, Michael M., Sikora, Andrew G., Lerner, Seth P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834740/
https://www.ncbi.nlm.nih.gov/pubmed/36643309
http://dx.doi.org/10.1016/j.heliyon.2022.e12570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834740/
https://www.ncbi.nlm.nih.gov/pubmed/36643309
http://dx.doi.org/10.1016/j.heliyon.2022.e12570

Ejemplares similares